Thursday's session: top gainers and losers

SPERO THERAPEUTICS INC (SPRO)       1.925   -0.01 (-0.77%)


News Image
Thursday's session: top gainers and losers2 months ago - Chartmill

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.

Top gainers

TickerChangeComment
SPRO168.0%SPERO THERAPEUTICS INC's (NASDAQ:SPRO) stock price is advancing with 168.0% to a price of $2.2. In the last 6 months the share price dropped with 89.92%.
BOA.W105.0%BOA ACQUISITION CL A -CW28 (NYSE:BOA.W) rose 105.0% to $0.14 during Thursday's after hours session. Shareholders saw the stock price going 65.5% lower in the past 3 months.
ATXI92.33%AVENUE THERAPEUTICS INC's (NASDAQ:ATXI) stock price is advancing with 92.33% to a price of $0.41. The stock is trading 65.23% lower than 6 months ago.
AVCT48.35%AMERICAN VIRTUAL CLOUD TECHN's (NASDAQ:AVCT) stock price is advancing with 48.35% to a price of $0.32. The stock is trading 53.27% higher than a month ago.
AVCTW46.4%PENSARE ACQUISITION CORP-CW's (NASDAQ:AVCTW) stock price is advancing with 46.4% to a price of $0.07. In the last 3 months the share price increased with 30.59%.
SAVA29.12%CASSAVA SCIENCES INC's (NASDAQ:SAVA) stock price increased by 29.12% to $48.6. In the last month the stock gained 48.72%.
SONN28.79%SONNET BIOTHERAPEUTICS HOLDI's (NASDAQ:SONN) stock price increased by 28.79% to $1.7. In the last month the stock lost 60.53%.
GSMGW26.42%GLORY STAR NEW -CW25's (NASDAQ:GSMGW) stock price increased by 26.42% to $0.02. In the last 3 months the share price increased with 78.65%.
BEAT24.68%HEARTBEAM INC's (NASDAQ:BEAT) shares rose 24.68% to $1.97 during Thursday's session. The stock is trading 20.61% higher than a month ago.
PIXY22.18%SHIFTPIXY INC's (NASDAQ:PIXY) stock price increased by 22.18% to $16.69. Shareholders saw the stock price going 41.32% lower in the past month.

For the full top gainers list go to our top gainers screener.

Losers

TickerChangeComment
MOHO-46.79%ECMOHO LTD's (NASDAQ:MOHO) shares fell 46.79% to $0.09 during Thursday's session. The stock is trading 31.61% lower than 6 months ago.
TOPS-23.9%TOP SHIPS INC's (NASDAQ:TOPS) stock price decreased by 23.9% to $0.16. Shareholders saw the stock price going 29.7% lower in the past month.
SOBR-23.43%SOBR SAFE INC's (NASDAQ:SOBR) stock price is declining with 23.43% to a price of $1.83. In the last month the share price increased with 115.0%.
OPP--23.08%River North Dble Line Strtgc Opp Fd [Opp/I/R]'s (NYSE:OPP-) shares fell 23.08% to $0.0. In the last month the share price dropped with 97.61%.
AYLA-20.0%AYALA PHARMACEUTICALS INC's (NASDAQ:AYLA) stock price is declining with 20.0% to a price of $0.88. In the last 6 months the share price dropped with 73.24%.
CPTN-19.38%CEPTON INC's (NASDAQ:CPTN) shares fell 19.38% to $1.69 during Thursday's session. A press release (Cepton Adds Lidar Digital Twin to NVIDIA DRIVE Sim, Advancing the Development of Safe Autonomous Driving Technology) was released yesterday.
LAZR-18.79%LUMINAR TECHNOLOGIES INC's (NASDAQ:LAZR) shares fell 18.79% to $7.61. In the last 3 months the share price increased with 25.1%.
AGRI-18.64%AGRIFORCE GROWING SYSTEMS LT's (NASDAQ:AGRI) stock price is declining with 18.64% to a price of $1.44. Shareholders saw the stock price going 29.2% lower in the past 3 months.
HSDT-18.41%HELIUS MEDICAL TECHNOLOGIES's (NASDAQ:HSDT) shares fell 18.41% to $0.36. In the last month the share price dropped with 38.41%.
JCSE-16.67%JE CLEANTECH HOLDINGS LTD's (NASDAQ:JCSE) shares fell 16.67% to $0.95 during Thursday's session. The stock is trading 40.93% lower than a month ago.

Our top losers screener will show you the full list.

Back

SPRO Links

SPRO News

News Image9 days ago - Spero Therapeutics, Inc.Spero Therapeutics to Present at the 5th Annual Evercore ISI HealthCONx Conference

CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical...

News Image17 days ago - Spero Therapeutics, Inc.Spero Therapeutics Announces Third Quarter 2022 Operating Results and Provides Business Update

Entered into and closed exclusive license agreement with GSK for tebipenem HBr, pursuant to which Spero receives $66 million upfront, and a $9 million...

News Image23 days ago - Spero Therapeutics, Inc.Spero Therapeutics Announces Closing of Exclusive License Agreement with GSK for Tebipenem HBr

Pursuant to the agreement, Spero will be receiving a $66 million upfront payment, received a $9 million direct equity investment in shares of Spero common...

News Image24 days ago - Spero Therapeutics, Inc.Spero Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial Results on Monday, November 14, 2022

CAMBRIDGE, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...

News Imagea month ago - Spero Therapeutics, Inc.Spero Therapeutics to Present Data at IDWeek 2022

CAMBRIDGE, Mass., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...

News Image2 months ago - Spero Therapeutics, Inc.Spero Therapeutics to Host Virtual R&D Event on Non-Tuberculous Mycobacterial Pulmonary Disease and the SPR720 Program

Event is taking place on Thursday, October 6th at 11:30 a.m. ET Event will feature a presentation by key opinion leader, Kevin L. Winthrop, MD, MPH...

Follow us for more